Allarity Therapeutics logo

Allarity Therapeutics

ALLR | NASDAQ
Chart Builder DCF Calculator
$0.88
-$0.07 (-7.74%)
At close: Nov 16, 2026, 4:00 PM ET
$0.94
+$0.06 (+6.41%)
After-hours: Nov 16, 2026, 7:40 PM ET
-7.74%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
40.5
+8.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #512/1021 (Top 50%)

Key Statistics

Market Data

Market Cap $13.93M
1D Range
0.87 0.97
52W Range
0.81 1.77

Valuation (TTM)

PE -0.90
PB -6.16
EV/EBITDA -1.70

Valuation (NTM)

Forward PE N/A
Forward PEG -0.77
Price Target $11.00
Loading financial charts...

Profile

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific c...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 21, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 13, 2026
EPS
-$0.39
Miss -85.71%
REV
$5K
Beat 0.00%
Next Earnings
Mar 29, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+1150.00%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.